AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3).

Diabetologia
A NerstedtMargit Mahlapuu

Abstract

The aim of the study was to examine the possible role of AMP-activated protein kinase (AMPK) in the regulation of the inflammatory response induced by cytokine action in human liver cells. IL-6-stimulated expression of the genes for acute-phase response markers serum amyloid A (SAA1, SAA2) and haptoglobin (HP) in the human hepatocarcinoma cell line HepG2 were quantified after modulation of AMPK activity by pharmacological agonists (5-amino-4-imidazole-carboxamideriboside [AICAR], metformin) or by using small interfering (si) RNA transfection. The intracellular signalling pathway mediating the effect of AMPK on IL-6-stimulated acute-phase marker expression was characterised by assessing the phosphorylation levels of the candidate protein signal transducer and activator of transcription 3 (STAT3) in response to AMPK agonists. AICAR and metformin markedly blunt the IL-6-stimulated expression of SAA cluster genes as well as of haptoglobin in a dose-dependent manner. Moreover, the repression of AMPK activity by siRNA significantly reversed the inhibition of SAA expression by both AICAR and metformin, indicating that the effect of the agonists is dependent on AMPK. For the first time we show that AMPK appears to regulate IL-6 signall...Continue Reading

References

Jan 1, 1992·The Biochemical Journal·M F VincentG Van den Berghe
Oct 2, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y YamadaN Fausto
Apr 5, 2001·American Journal of Physiology. Endocrinology and Metabolism·P A KernG Ranganathan
May 26, 2001·The Journal of Clinical Investigation·J S CampbellN Fausto
Jul 24, 2001·JAMA : the Journal of the American Medical Association·A D PradhanP M Ridker
Sep 3, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Mark A Febbraio, Bente Klarlund Pedersen
Nov 28, 2002·Diabetes·Joseph J SennRobert A Mooney
May 30, 2003·The Biochemical Journal·Peter C HeinrichFred Schaper
Oct 16, 2003·American Journal of Physiology. Endocrinology and Metabolism·Margit MahlapuuStefan Marklund
Oct 28, 2003·Diabetes·Peter J KloverRobert A Mooney
Dec 31, 2003·Biochemical and Biophysical Research Communications·Claudia Oller do NascimentoPaul Trayhurn
Jan 15, 2004·The Journal of Clinical Investigation·John W ScottD Grahame Hardie
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·Priya MohantyParesh Dandona
Jun 29, 2004·Biochemical and Biophysical Research Communications·Meghan KellyNeil B Ruderman
Jul 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kohjiro UekiC Ronald Kahn
Mar 1, 2005·Biochimie·David Carling
May 3, 2005·The Journal of Clinical Investigation·Kathryn E Wellen, Gökhan S Hotamisligil
Aug 20, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·A M CarterP J Grant
Apr 4, 2006·Cell Metabolism·Hiroshi InoueMasato Kasuga
Apr 11, 2006·Nature Medicine·Matthew J WattGregory R Steinberg
Jul 11, 2006·The Journal of Clinical Investigation·Yun Chau Long, Juleen R Zierath
Dec 15, 2006·Nature·Gökhan S Hotamisligil
Feb 3, 2007·The Journal of Biological Chemistry·Christian X AnderssonUlf Smith
Sep 20, 2007·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·T-B KimK-Y Lee
Jul 1, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Xia ZhaoEdward Abraham
Sep 18, 2008·International Journal of Obesity : Journal of the International Association for the Study of Obesity·D CarlingA Woods

❮ Previous
Next ❯

Citations

Aug 1, 2013·Nature Communications·Alejandro Martin-MontalvoRafael de Cabo
Feb 6, 2013·Proceedings of the National Academy of Sciences of the United States of America·Brendan GongolJohn Y-J Shyy
Jan 27, 2011·American Journal of Physiology. Endocrinology and Metabolism·R KrishnapuramN V Dhurandhar
Apr 6, 2013·International Immunopharmacology·Kwi Young KangJi Hyeon Ju
Jul 12, 2014·Human Reproduction Update·Vanitha N SivalingamEmma J Crosbie
Jun 15, 2012·Expert Opinion on Investigational Drugs·Ian P Salt, Timothy M Palmer
Feb 6, 2015·Tuberculosis and Respiratory Diseases·Jae Seung LeeSang-Do Lee
Jan 23, 2016·Oxidative Medicine and Cellular Longevity·Martha Lucinda Contreras-Zentella, Rolando Hernández-Muñoz
May 11, 2013·American Journal of Obstetrics and Gynecology·Neeraj DesaiChristine N Metz
Dec 3, 2014·Biochemical and Biophysical Research Communications·Byung-Hak KimSang-Kyu Ye
Apr 28, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Efrat FortiSmadar Cohen
Jun 3, 2017·American Journal of Physiology. Lung Cellular and Molecular Physiology·Chansutha ThangaratnarajahMiguel A Alejandre Alcázar
Oct 5, 2010·American Journal of Respiratory Cell and Molecular Biology·Seónadh O'LearyJoseph Keane
Mar 13, 2012·Pharmacological Reviews·E J Verspohl
Jun 5, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Emmelie CansbyMargit Mahlapuu
Jul 19, 2020·International Journal of Molecular Sciences·Shengnan Wu, Ming-Hui Zou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.